Ann Aerts has stared death in the eye. The head of the non-profit Novartis Foundation lost colleagues when she was serving as an emergency medicine physician on a medical mission in a dangerously unstable country.
Patients with multiple sclerosis, an autoimmune disease that affects 2.5 million worldwide, lose brain volume three to five times faster than people without the disease.
Morning is the most challenging time of day for many patients with COPD, who may have shortness of breath, coughing and difficulty getting ready.
The head of Public Affairs for the Novartis Malaria Initiative has a malaria story of her own to tell.
Ricardo Dolmetsch was living the scientific dream by his mid-30s. Already a professor at Stanford University, he was running a successful lab, winning grants and receiving recognition for work in an area of neuroscience called calcium channel signaling. But then his son was diagnosed with autism.
More than 125 million people globally live with psoriasis, a chronic autoimmune disease that causes red, scaly patches to appear on the skin.
The cause of a rare, inherited, often fatal kidney disease in many patients remained elusive for years, despite multiple attempts to solve the mystery. Then in 2012, a team of researchers cracked some of the unsolved cases in just six weeks.
Drawing on the wealth of available data about human biology and genomics, as well as the in-house expertise of a global network of researchers, NIBR has developed new and important therapies.
Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society report.
This site is intended for a global audience.